<p>，/PRNewswire/ -- Ademi 律师事务所正在调查 Generation Bio（纳斯达克：GBIO）在其最近宣布与 XOMA Royalty Corporation 交易中可能存在的信托责任违反和其他法律违规行为。</p>
<p>点击这里了解如何加入我们的调查并获取更多信息，或通过 [email protected] 与我们联系，或拨打免费电话：866-264-3995。您无需支付任何费用或承担任何义务。</p>
<p>在此次交易中，Generation Bio 的股东将每股获得 4.2913 美元现金以及每股一个附带价值权。附带价值权将使持有者有权在交易完成时获得超过 2900 万美元的净现金部分、Generation Bio 在剑桥办公室租赁义务中的潜在节省，以及 Generation Bio 与 Moderna 现有许可协议的收益，该协议包括开发和商业里程碑及版税。</p>
<p>Generation Bio 的内部人士将在控制权变更安排中获得可观的利益。</p>
<p>交易协议不合理地限制了 Generation Bio 的竞争交易，若 Generation Bio 接受竞争报价将面临重大罚款。我们正在调查 Generation Bio 董事会的行为，以及他们是否履行了对所有股东的信托责任。</p>
<p>我们专注于涉及收购、合并和个人股东权利的股东诉讼。如需更多信息，请随时与我们联系。律师广告。以往的结果并不保证类似的结果。</p>
<p>联系方式</p>
<p>Ademi &amp; Fruchter LLP</p>
<p>Guri Ademi</p>
<p>免费电话：（866）264-3995</p>
<p>传真：（414）482-8001</p>
<p>来源：Ademi LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2"/></p>

GBIO

<p>Ademi 律师事务所正在调查 Generation Bio 在与 XOMA Royalty Corporation 交易中是否存在潜在的信托责任违规行为。股东将获得每股 4.2913 美元的现金以及附带的价值权利。该交易限制了竞争性出价，并使内部人士受益。调查的重点是董事会是否履行了其信托责任。如需更多信息，请联系 Ademi & Fruchter LLP</p>

<p>, /PRNewswire/ -- The Ademi Firm is investigating Generation Bio (Nasdaq: GBIO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XOMA Royalty Corporation.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Ademi 律师事务所正在调查 Generation Bio（纳斯达克：GBIO）在其最近宣布与 XOMA Royalty Corporation 交易中可能存在的信托责任违反和其他法律违规行为。</p>
</div><p>Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.</p>
<div class="lb-trans"><p>点击这里了解如何加入我们的调查并获取更多信息，或通过 [email protected] 与我们联系，或拨打免费电话：866-264-3995。您无需支付任何费用或承担任何义务。</p>
</div><p>In the transaction, Generation Bio shareholders will own $4.2913 per share in cash plus one contingent value right per share. The CVRs will entitle holders to receive portions of net cash above $29 million at closing, potential savings from Generation Bio's Cambridge office lease obligations, and proceeds from Generation Bio's existing license agreement with Moderna, which includes development and commercial milestones and royalties.</p>
<div class="lb-trans"><p>在此次交易中，Generation Bio 的股东将每股获得 4.2913 美元现金以及每股一个附带价值权。附带价值权将使持有者有权在交易完成时获得超过 2900 万美元的净现金部分、Generation Bio 在剑桥办公室租赁义务中的潜在节省，以及 Generation Bio 与 Moderna 现有许可协议的收益，该协议包括开发和商业里程碑及版税。</p>
</div><p>Generation Bio insiders will receive substantial benefits as part of change of control arrangements.</p>
<div class="lb-trans"><p>Generation Bio 的内部人士将在控制权变更安排中获得可观的利益。</p>
</div><p>The transaction agreement unreasonably limits competing transactions for Generation Bio by imposing a significant penalty if Generation Bio accepts a competing bid. We are investigating the conduct of the Generation Bio board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.</p>
<div class="lb-trans"><p>交易协议不合理地限制了 Generation Bio 的竞争交易，若 Generation Bio 接受竞争报价将面临重大罚款。我们正在调查 Generation Bio 董事会的行为，以及他们是否履行了对所有股东的信托责任。</p>
</div><p>We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>我们专注于涉及收购、合并和个人股东权利的股东诉讼。如需更多信息，请随时与我们联系。律师广告。以往的结果并不保证类似的结果。</p>
</div><p>Contacts</p>
<div class="lb-trans"><p>联系方式</p>
</div><p>Ademi &amp; Fruchter LLP</p>
<div class="lb-trans"><p>Ademi &amp; Fruchter LLP</p>
</div><p>Guri Ademi</p>
<div class="lb-trans"><p>Guri Ademi</p>
</div><p>Toll Free: (866) 264-3995</p>
<div class="lb-trans"><p>免费电话：（866）264-3995</p>
</div><p>Fax: (414) 482-8001</p>
<div class="lb-trans"><p>传真：（414）482-8001</p>
</div><p>SOURCE Ademi LLP</p>
<div class="lb-trans"><p>来源：Ademi LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG48146&amp;Transmission_Id=202512152021PR_NEWS_USPR_____CG48146&amp;DateId=20251215"/></p>

股东警示：Ademi 公司正在调查 Generation Bio Co.是否为其公众股东争取到了公平的价格